Revolution Medicines Inc.

NASDAQ: RVMD · Real-Time Price · USD
36.30
0.28 (0.78%)
At close: Aug 15, 2025, 3:59 PM
36.32
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Revolution Medicines Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-600.09M -436.37M -248.71M -187.09M
Depreciation & Amortization
-43.5M 9.31M 9.66M 7.33M
Stock-Based Compensation
79.2M 61.77M 31.2M 20.72M
Other Working Capital
5.62M 864K -22.03M -1.66M
Other Non-Cash Items
6.55M -18.13M -2.64M 3.13M
Deferred Income Tax
-762K -3.91M -419K n/a
Change in Working Capital
406K 36.75M -13.49M 8.72M
Operating Cash Flow
-557.44M -350.57M -224.4M -147.18M
Capital Expenditures
-10.31M -7.73M -10.82M -6.53M
Cash Acquisitions
n/a n/a 13.3M 135.59M
Purchase of Investments
-2.14B -1.06B -612.77M -671.34M
Sales Maturities Of Investments
1.59B 724.05M 599.47M 535.75M
Other Investing Acitivies
n/a n/a -13.3M -135.59M
Investing Cash Flow
-554.39M -342.6M -24.12M -142.12M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a 3.32M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
113.06M 843.44M 3.39M 2.94M
Financial Cash Flow
959.41M 1.23B 301.43M 294.18M
Net Cash Flow
-152.42M 536.03M 52.91M 4.88M
Free Cash Flow
-567.74M -358.3M -235.22M -153.71M